Maravai LifeSciences (MRVI) Social Stream
MARAVAI LIFESCIENCES HOLDINGS INC (MRVI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MARAVAI LIFESCIENCES HOLDINGS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-19 | 8 | $62 | $32 | $53.428 | $13.74 | 288.85% |
| 2021-11-11 | 8 | $65 | $32 | $52.714 | $13.74 | 283.65% |
| 2022-01-23 | 6 | $59 | $49 | $54.833 | $13.74 | 299.08% |
| 2022-02-08 | 6 | $59 | $42 | $52.333 | $13.74 | 280.88% |
| 2022-02-24 | 6 | $58 | $42 | $48.5 | $13.74 | 252.98% |
| 2022-05-06 | 6 | $54 | $40 | $46.2 | $13.74 | 236.24% |
| 2022-05-09 | 6 | $49 | $40 | $44.333 | $13.74 | 222.66% |
| 2022-05-20 | 6 | $49 | $40 | $43.833 | $13.74 | 219.02% |
| 2022-07-19 | 7 | $49 | $35 | $42.571 | $13.74 | 209.83% |
| 2022-08-05 | 7 | $40 | $30 | $35.571 | $13.74 | 158.89% |
| 2022-08-13 | 7 | $40 | $30 | $34.428 | $13.74 | 150.57% |
| 2022-10-23 | 7 | $37 | $30 | $34 | $13.74 | 147.45% |
| 2022-11-04 | 7 | $35 | $17 | $26.428 | $13.74 | 92.34% |
| 2022-12-07 | 8 | $32 | $17 | $23.75 | $13.74 | 72.85% |
| 2023-01-03 | 9 | $32 | $17 | $23.888 | $13.74 | 73.86% |
| 2023-02-08 | 10 | $32 | $16 | $23.1 | $13.74 | 68.12% |
| 2023-02-24 | 10 | $32 | $15 | $21.9 | $13.74 | 59.39% |
| 2023-03-01 | 11 | $32 | $15 | $21.6 | $13.74 | 57.21% |
The Trend in the Analyst Price Target
Over the past 43 weeks, MRVI's average price target has gone down $24.6.
MRVI reports an average of 56.94% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-19 | 7 | 49 | 35 | 42.571 | 26.79 | 58.91% |
| 2022-10-17 | 7 | 37 | 30 | 34.000 | 19.42 | 75.08% |
| 2022-12-07 | 8 | 32 | 17 | 23.750 | 12.71 | 86.86% |
| 2022-12-14 | 9 | 32 | 17 | 23.888 | 15.13 | 57.88% |
| 2023-03-01 | 11 | 32 | 15 | 21.600 | 14.97 | 44.29% |
MRVI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 7 | 2 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 16 months, MRVI's average broker recommendation rating worsened by 0.41.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- MRVI has a greater upside potential (average analyst target price relative to current price) than 1787.15% of all US stocks.
- MARAVAI LIFESCIENCES HOLDINGS INC's number of analysts covering the stock is greater than 351.82% of stocks in the large market cap category.
- In terms of how MARAVAI LIFESCIENCES HOLDINGS INC fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 500.81% of that group.
- MARAVAI LIFESCIENCES HOLDINGS INC's variance in analysts' estimates is lower than -941.79% of stocks in the large market cap category.
In the Pharmaceutical Products industry, ABCL, RVMD, and BEAM are the three stocks most similar to MARAVAI LIFESCIENCES HOLDINGS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is MRVI a Buy, Hold or Sell? See the POWR Ratings now!